Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women

Launched by INSTITUTO MÉDICO TECNOLÓGICO SL · Nov 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new telerehabilitation program designed to help menopausal women improve their sexual function and reduce pain during intercourse, a condition known as dyspareunia. The goal is to see if this online therapy is as effective as traditional face-to-face physiotherapy in enhancing quality of life for these women.

To be eligible for the study, participants must be women aged 45 to 65 who are experiencing dyspareunia for at least three months. They will need to agree to fill out questionnaires and provide consent to participate. The study is not yet recruiting participants, but if you qualify and decide to join, you can expect to engage in the telerehabilitation program from home, with guidance from professionals. It's important to note that women with certain medical conditions or treatments, such as recent surgeries or specific diseases, won't be able to participate to ensure everyone's safety.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Female
• • Age from 45 to 65 years.
• • Menopausal
• • Suffer dyspareunia for 3 months of evolution.
• • Willing to complete study questionnaires and informed consent study.
• Exclusion Criteria:
• • Pacemaker or other types of electronic implant.
• • Thrombophlebitis.
• • Skin hypersensitivity or rejection of manual contact.
• • Active or previous treatment with chemotherapy or radiotherapy in the pelvic area.
• • Wounds or burns in the pelvic area.
• • Allergy to nickel and chromium.
• • Other pelvic floor physiotherapy treatments during the study intervention.
• • Other medical and surgical treatments in the pelvic region, such as muscle infiltrations or nerve blocks during the study intervention.
• • Surgical intervention in the pelvic area in the last 3 months.
• • Fibromyalgia.
• • Oncological processes that affect the sacrum.
• • Systemic diseases (infectious, vascular, endocrine, metabolic or neoplastic conditions).
• • Neuromuscular diseases (Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Myasthenia Gravis or spinal muscular atrophy).
• • Myelopathy and Osteomyelitis.
• • Diseases that cause alterations of the central nervous system (traumatic or vascular spinal cord injury).
• • Neurological or metabolic conditions that affect the ability to respond (Diabetes, Parkinson's disease, senile dementia, etc).
• • Serious mental disorder.